Developing Novel Antibiotics Consultancy

Breaking News

I am pleased to report that nitrile antimicrobial medical examination gloves had its European Product Launch in London on May 31st 2018. 

The nitrile antimicrobial examination gloves were developed by Hartalega, the largest manufacturer of nitrile examination gloves in the world, using antimicrobial technology developed by Chemical Intelligence Limited, a small UK company that I have worked with for several years. The antimicrobial, which has impressive efficacy against a range of HAI pathogens, is incorporated in the outer surface of the gloves only during manufacture, is not related to any clinically useful antibiotic and does not leach from the gloves. The cost of manufacture of the nitrile antimicrobial examination gloves will be similar to standard nitrile examination gloves.

A short video explaining how the antimicrobial works and including some expert opinions on the gloves can be viewed at; 

www.youtube.com/watch?v=uYEJO602YGA&feature=youtu.be


Antibiotic Resistance

Dame Sally Davies, the Chief Medical Officer (England) said in 2013 that "Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics." About 25,000 patients a year die in the European Union from an infection caused by a bacterium that is resistant to more than one antibiotic – and on current trends this is predicted to grow to 390,000 a year by 2050. Further information on the scale of the problem of antibiotic resistance can be found here.

The Developing Novel Antibiotics Consultancy was started in November 2015 by Professor Richard James to provide advice  to antibiotic developers and potential investors concerning alternatives to traditional antibiotic discovery, specifically concentrating on the following;

There is developing evidence that these approaches could make a significant contribution to overcoming the problem of antimicrobial resistance.  By making use of a relationship with a long established UK consultancy business I can also offer expertise in traditional small molecule antibiotics.

Professor James also has extensive experience acting as an Expert Witness in civil disputes; further information can be found here.

The Developing Novel Antibiotics Consultancy carries Professional indemnity, Public and products liability, and Employers' liability insurance.


See  @RichardJames39 for my latest tweets on AMR, bacteriocins and phage therapy